Surrozen, Inc./DE (SRZN): who owns it and who trades it
As of Nov 16, 2026, SRZN insiders reported 6 open-market sales worth $3.8M and 33 purchases worth $5.4M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Chen-Ming Yu (10% owner), with $3.5M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Surrozen
From the latest filingsOverall: more buying than selling. Funds, insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns SRZN
70 funds and institutions reported SRZN shares worth $275M at the end of Q2 2026, about 94% of the company. The largest holder is TCG Crossover Management, LLC with 12.8%.
Funds and institutions (13F) 94%Everyone else 6%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 1.47M | 12.82% | $38.2M | No change |
| Boxer Capital Management, LLC | 1.11M | 9.63% | $27M | +44% |
| Kalehua Capital Management LLC | 770,356 | 6.71% | $20M | No change |
| Millennium Management LLC | 683,079 | 5.95% | $17.7M | -7% |
| Point72 Asset Management, L.P. | 664,272 | 5.78% | $17.2M | New |
| Venrock Adviser, LLC | 632,931 | 5.51% | $16.4M | No change |
| Stempoint Capital LP | 602,798 | 5.25% | $13.8M | -16% |
| Perceptive Advisors LLC | 503,985 | 4.39% | $13.1M | +120% |
| Spruce Street Capital LP | 432,040 | 3.76% | $11.2M | No change |
| BlackRock, Inc. | 394,864 | 3.44% | $10.2M | +1318% |
| Vanguard Capital Management LLC | 392,550 | 3.42% | $10.2M | +132% |
| Braidwell LP | 390,753 | 3.40% | $10.1M | -1% |
| Vestal Point Capital, LP | 304,669 | 2.65% | $7.9M | -10% |
| 5AM Venture Management, LLC | 271,250 | 2.36% | $7M | -30% |
| Vivo Capital, LLC | 260,000 | 2.26% | $6.7M | No change |
| Balyasny Asset Management L.P. | 205,032 | 1.78% | $5.3M | +1% |
| Geode Capital Management, LLC | 201,652 | 1.76% | $5.2M | +206% |
| Acuta Capital Partners, LLC | 173,395 | 1.51% | $4.5M | +0% |
| Regents of the University of California | 133,207 | 1.16% | $3.5M | No change |
| State Street Corp | 133,084 | 1.16% | $3.5M | +380% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, SRZN insiders reported $5.4M of open-market purchases and $3.8M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Chen-Ming Yu +4 | 10% owner | Sale | 162,500 | $21.25 | $3.5M | Form 4 |
| May 4, 2026 | Yang Li | Vice president | Sale | 1,584 | $33.33 | $52.8K | Form 4 |
| May 4, 2026 | Charles O Williams | Chief Operating Officer | Sale | 2,036 | $33.33 | $67.9K | Form 4 |
| May 4, 2026 | Craig C Parker | CEO | Sale | 4,524 | $33.33 | $151K | Form 4 |
| Mar 24, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 53,329 | $24.69 | $1.3M | Form 4 |
| Mar 23, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 7,612 | $24.90 | $190K | Form 4 |
| Mar 23, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 7,611 | $24.90 | $190K | Form 4 |
| Mar 16, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 595 | $24.99 | $14.9K | Form 4 |
| Mar 13, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 17,717 | $24.88 | $441K | Form 4 |
| Mar 13, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 17,716 | $24.88 | $441K | Form 4 |
| Mar 12, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 6,187 | $24.99 | $155K | Form 4 |
| Feb 12, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 546 | $23.86 | $13K | Form 4 |
| Feb 12, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 547 | $23.86 | $13.1K | Form 4 |
| Feb 11, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 8,882 | $23.58 | $209K | Form 4 |
| Feb 11, 2026 | TCG Crossover Fund II, L.P. +3 | 10% owner | Purchase | 8,881 | $23.58 | $209K | Form 4 |
| Feb 3, 2026 | TCG Crossover GP III, LLC +3 | 10% owner | Purchase | 2,178 | $21.94 | $47.8K | Form 4 |
| Feb 3, 2026 | TCG Crossover GP III, LLC +3 | 10% owner | Purchase | 2,177 | $21.94 | $47.8K | Form 4 |
| Feb 2, 2026 | TCG Crossover GP III, LLC +3 | 10% owner | Purchase | 366 | $21.38 | $7.8K | Form 4 |
| Feb 2, 2026 | TCG Crossover GP III, LLC +3 | 10% owner | Purchase | 365 | $21.38 | $7.8K | Form 4 |
| Jan 30, 2026 | TCG Crossover GP III, LLC +3 | 10% owner | Purchase | 2,136 | $21.39 | $45.7K | Form 4 |
| Jan 30, 2026 | TCG Crossover GP III, LLC +3 | 10% owner | Purchase | 2,135 | $21.39 | $45.7K | Form 4 |
| Jan 20, 2026 | Column Group Opportunity III GP, LP +6 | 10% owner | Purchase | 9,568 | $19.60 | $188K | Form 4 |
| Jan 20, 2026 | Column Group Opportunity III GP, LP +6 | 10% owner | Purchase | 8,484 | $19.60 | $166K | Form 4 |
| Jan 16, 2026 | Column Group Opportunity III GP, LP +6 | 10% owner | Purchase | 1,358 | $20.00 | $27.2K | Form 4 |
| Jan 16, 2026 | Column Group Opportunity III GP, LP +6 | 10% owner | Purchase | 1,204 | $20.00 | $24.1K | Form 4 |
| Jan 15, 2026 | Column Group Opportunity III GP, LP +6 | 10% owner | Purchase | 5,590 | $19.89 | $111K | Form 4 |
| Jan 15, 2026 | Column Group Opportunity III GP, LP +6 | 10% owner | Purchase | 6,303 | $19.89 | $125K | Form 4 |
| Jan 14, 2026 | Tim Kutzkey | Director | Purchase | 2,927 | $19.99 | $58.5K | Form 4 |
| Jan 14, 2026 | Tim Kutzkey | Director | Purchase | 2,596 | $19.99 | $51.9K | Form 4 |
| Jan 13, 2026 | Tim Kutzkey | Director | Purchase | 5,861 | $19.80 | $116K | Form 4 |
| Jan 13, 2026 | Tim Kutzkey | Director | Purchase | 6,609 | $19.80 | $131K | Form 4 |
| Jan 6, 2026 | Column Group Iii Gp, Lp +6 | 10% owner | Purchase | 7,097 | $19.89 | $141K | Form 4 |
| Jan 6, 2026 | Column Group Iii Gp, Lp +6 | 10% owner | Purchase | 8,003 | $19.89 | $159K | Form 4 |
| Jan 5, 2026 | Yang Li | Vice president | Sale | 1,118 | $19.87 | $22.2K | Form 4 |
| Jan 5, 2026 | Charles O Williams | Chief Operating Officer | Sale | 1,566 | $19.87 | $31.1K | Form 4 |
| Dec 5, 2025 | Tim Kutzkey | Director | Purchase | 16,381 | $19.54 | $320K | Form 4 |
| Dec 5, 2025 | Tim Kutzkey | Director | Purchase | 14,503 | $19.54 | $283K | Form 4 |
| Dec 4, 2025 | Tim Kutzkey | Director | Purchase | 2,791 | $17.35 | $48.4K | Form 4 |
| Dec 4, 2025 | Tim Kutzkey | Director | Purchase | 2,475 | $17.35 | $42.9K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Chen-Ming Yu | 10% owner | – | $3.5M | Jul 22, 2026 |
| TCG Crossover Fund II, L.P. | 10% owner | $3.2M | – | Mar 24, 2026 |
| Tim Kutzkey | Director, 10% owner | $1.1M | – | Jan 14, 2026 |
| Column Group Opportunity III GP, LP | 10% owner | $642K | – | Jan 20, 2026 |
| Column Group Iii Gp, Lp | 10% owner | $300K | – | Jan 6, 2026 |
| TCG Crossover GP III, LLC | 10% owner | $203K | – | Feb 3, 2026 |
| Craig C Parker | Chief Executive Officer, Director | – | $151K | May 4, 2026 |
| Charles O Williams | Chief Operating Officer | – | $99K | May 4, 2026 |
| Yang Li | Exec. Vice President, Research | – | $75K | May 4, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
SRZN short interest
Very high short interest. 27.5% of SRZN shares are sold short: about 1 share in 4. Over the last 12 reports the number of shares short went up 492%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 3.23M SRZN shares were sold short, 27.5% of the shares outstanding, up 3.3% from the report before. At the average daily volume of 379,990 shares, buying them all back would take about 8.5 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.23M | 27.52% | +3% | 379,990 | 8.5 |
| Oct 15, 2026 | 3.13M | 26.64% | +43% | 656,838 | 4.8 |
| Sep 30, 2026 | 2.19M | 18.63% | -0% | 1.45M | 1.5 |
| Sep 15, 2026 | 2.20M | 18.68% | +52% | 173,121 | 12.7 |
| Aug 31, 2026 | 1.45M | 12.30% | +15% | 187,095 | 7.7 |
| Aug 14, 2026 | 1.25M | 10.66% | +9% | 258,969 | 4.8 |
| Jul 31, 2026 | 1.15M | 10.01% | +18% | 283,082 | 4.1 |
| Jul 15, 2026 | 970,957 | 8.45% | +37% | 155,834 | 6.2 |
| Jun 30, 2026 | 709,757 | 6.18% | +105% | 229,914 | 3.1 |
| Jun 15, 2026 | 346,034 | 3.01% | -37% | 97,035 | 3.6 |
| May 29, 2026 | 551,841 | 4.80% | +1% | 101,544 | 5.4 |
| May 15, 2026 | 546,224 | 4.76% | -3% | 85,109 | 6.4 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Surrozen company events
Surrozen filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 9, 2026.
- Nov 9, 2026ResultsReleased financial results. Filing
- Oct 20, 2026SharesSold new shares outside a public offering. Filing
- Oct 2, 2026AnnouncementSurrozen, Inc. (Surrozen) announced U.S. Food and Drug Administration (FDA) clearance of our Investigational New Drug (IND) application for SZN-8141, enabling us to advance the program into clinical development. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- May 14, 2026VoteReported shareholder vote results. Filing
- May 6, 2026ResultsReleased financial results. Filing
- Mar 23, 2026ResultsReleased financial results. Filing
- Jan 30, 2026LeadershipShao-Lee Lin, M.D., Ph.D. resigned from the Board of Directors of Surrozen, Inc., or the Company, effective immediately. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Surrozen financials
Famous investors that hold SRZN
4 of the 50 well-known investors we track reported holding SRZN in their latest 13F filing. The largest position is Steve Cohen's, worth $26M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Steve Cohen · Point72 Asset Management | Q3 2026 | 806,407 | $26M | 0.0% | +21% |
| Israel Englander · Millennium Management | Q3 2026 | 596,130 | $19.2M | 0.0% | -13% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 63,136 | $2M | 0.0% | +410% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 35,571 | $1.1M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 20 filings named SRZN in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | BALYASNY ASSET MANAGEMENT L.P. | 13G | 5.6% |
| Nov 16, 2026 | BALYASNY ASSET MANAGEMENT L.P. | 13G | 5.6% |
| Nov 16, 2026 | 5AM Partners VII, LLC | 13G/A | 3.9% |
| Nov 16, 2026 | Point72 Asset Management, L.P. | 13G/A | 6.9% |
| Nov 16, 2026 | StemPoint Capital LP | 13G/A | 3.5% |
| Nov 16, 2026 | Point72 Asset Management, L.P. | 13G/A | 6.9% |
| Nov 16, 2026 | StemPoint Capital LP | 13G/A | 3.5% |
| Nov 16, 2026 | TCG Crossover GP II, LLC | 13G/A | 0.0% |
| Nov 16, 2026 | 5AM Partners VII, LLC | 13G/A | 3.9% |
| Nov 16, 2026 | TCG Crossover GP II, LLC | 13G/A | 0.0% |
| Nov 13, 2026 | Integrated Core Strategies (US) LLC | 13G/A | 2.9% |
| Nov 13, 2026 | Integrated Core Strategies (US) LLC | 13G/A | 2.9% |
| Nov 6, 2026 | The Column Group III GP, LP | 13D/A | 16.6% |
| Nov 6, 2026 | The Column Group III GP, LP | 13D/A | 16.6% |
| Oct 22, 2026 | The Column Group III GP, LP | 13D/A | 16.6% |
| Oct 22, 2026 | The Column Group III GP, LP | 13D/A | 16.6% |
| Oct 7, 2026 | Boxer Capital Management, LLC | 13G/A | 11.6% |
| Oct 7, 2026 | Boxer Capital Management, LLC | 13G/A | 11.6% |
| Oct 1, 2026 | Commodore Capital LP | 13G | 7.5% |
| Oct 1, 2026 | Commodore Capital LP | 13G | 7.5% |
Questions about Surrozen, Inc./DE (SRZN) stock
Who owns the most SRZN stock?
The largest reported owner of Surrozen, Inc./DE (SRZN) is TCG Crossover Management, LLC, with 12.8% of the company. In total, 70 funds and institutions reported holding SRZN at the end of Q2 2026, together about 94% of the shares. See the largest owners.
Are SRZN insiders buying or selling?
In the last 12 months, SRZN insiders reported 33 open-market purchases worth $5.4M and 6 sales worth $3.8M. The latest trade was on Jul 22, 2026. See every trade.
What is the short interest in SRZN?
As of Oct 30, 2026, 3.23M SRZN shares were sold short, 27.5% of the shares outstanding, up 3.3% from the report before. At the average daily volume of 379,990 shares, buying them all back would take about 8.5 trading days (days to cover). See the history.
Which famous investors hold SRZN?
4 of the 50 well-known investors we track reported SRZN in their latest 13F filing, including Steve Cohen, Israel Englander, Jim Simons. The largest position is worth $26M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.